Test Price
2,800 AED✅ Home Collection Available
RFX6 Gene Maturity-Onset Diabetes of the Young (MODY) Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
Why This Test Matters
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited next‑generation sequencing (NGS) for the full RFX6 coding region.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM–11 PM for peripheral blood or dried blood spot (FTA card).
- Clinical Guidance: Telephonic post‑test interpretation & personalised result counselling by DHA‑licensed genetics specialists.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
This test detects pathogenic variants in the RFX6 gene associated with maturity‑onset diabetes of the young (MODY). A confirmed diagnosis enables targeted therapy, improves glycaemic control, and informs family screening. All laboratory processes adhere to UAE Federal Law No. 2 of 2019 and the Personal Data Protection Law (PDPL).
Test Overview & Methodology
The RFX6 MODY genetic test uses next‑generation sequencing (NGS) to analyse the entire coding region and splice sites of the RFX6 gene, including detection of copy number variants. This approach offers a higher diagnostic yield compared to targeted genotyping of known single‑nucleotide polymorphisms (SNPs) alone.
| Feature | DNA Labs UAE – RFX6 MODY Test | Closest Alternative |
|---|---|---|
| Methodology | NGS (full gene coverage + copy number variant detection) | Targeted genotyping of known SNPs only |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Sample Type | Whole blood (EDTA), FTA card (dried blood spot), or extracted DNA | Venous whole blood only |
| Pre‑test Genetic Counselling | Included – pedigree charting & DHA‑guided session | Often not provided |
Physician Insight & Safety Protocols
“At DNA Labs UAE, we recognise the emotional weight that comes with a possible genetic diabetes diagnosis. This test yields vital information, but every result must be interpreted in light of your full clinical picture, family history, and glucose monitoring. Please, never stop prescribed medication without a doctor’s guidance – let our result empower, not replace, your ongoing care.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Reg. ID: 9294403)
Advisory: Medication Guidance
Do not discontinue prescribed medication without consulting your treating physician. This genetic test informs long‑term management, not acute treatment.
Safety & Exclusion Criteria
- Exclusion Criteria: Active febrile illness, recent blood transfusion (within 7 days), or severe anaemia may necessitate rescheduling the blood draw. Pregnant women can undergo the test safely; please inform the phlebotomist.
- Emergency Red Flags: If you experience sudden severe hyperglycaemia, diabetic ketoacidosis symptoms, or loss of consciousness, seek emergency medical help. This test is not a substitute for urgent care.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the RFX6 MODY genetic test?
This test identifies pathogenic RFX6 mutations that confirm a diagnosis of maturity‑onset diabetes of the young, enabling tailored therapy and accurate prediction of disease course. Positive results can direct the use of sulfonylureas instead of insulin, dramatically improving quality of life and reducing unnecessary treatment. It also clarifies recurrence risk for family members and supports early screening of at‑risk relatives.
2. How should I prepare for the sample collection?
Preparation is minimal: if using an FTA card, a single drop of blood is allowed to air‑dry at room temperature; if venous draw, routine precautions apply. No fasting is required for the genetic test itself. Our mobile phlebotomy team handles all logistics, including cold‑chain preservation. Please inform the phlebotomist if you are pregnant or have any bleeding disorder.
3. Does insurance cover this test in the UAE?
Coverage varies by provider; we verify your benefits directly and handle billing, so you receive a clear financial confirmation before sample collection. Send your insurance card via WhatsApp to +971 54 548 8731, and our team will confirm eligibility within hours – no upfront payment required if approved.
UAE Regulatory & Data Privacy Adherence
- All laboratory processes comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – your genetic information is stored on encrypted, local servers.
- Health data handling adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- DHA Facility License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
- Corporate Lab Branding: DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | RFX6 Gene Maturity-Onset Diabetes of the Young (MODY) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), FTA card (dried blood spot), or extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD‑10‑CM Code | E13.9, Z13.1, Z15.89 |
| LOINC Code | 69777-2 |
| DHA Facility License & Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians